Charge effect of water-soluble porphyrin derivatives as a prototype to fight infections caused by Acinetobacter baumannii by aPDT approaches

References

• Alves E, Costa L, Carvalho CM, Tomé JP, Faustino MA, Neves MG, Tomé AC, Cavaleiro JA, Cunh A, Almeida A. 2009. Charge effect on the photoinactivation of gram-negative and gram-positive bacteria by cationic meso-substituted porphyrins. BMC Microbiol. 9:70–13. doi:10.1186/1471-2180-9-70.
   PubMed Web of Science ®Google Scholar
• Anju VT, Paramanantham P, SB SL, Sharan A, Syed A, Bahkali NA, Alsaedi MH, K K, Busi S. 2019a. Antimicrobial photodynamic activity of toluidine blue-carbon nanotube conjugate against Pseudomonas aeruginosa and Staphylococcus aureus - understanding the mechanism of action. Photodiagn Photodyn Ther. 27:305–316. doi:10.1016/j.pdpdt.2019.06.014.
   PubMed Web of Science ®Google Scholar
• Anju VT, Paramanantham P, Siddhardha B, Lal SBS, Sharan A, Alyousef AA, Arshad M, Syed A. 2019b. Malachite green-conjugated multi-walled carbon nanotubes potentiate antimicrobial photodynamic inactivation of planktonic cells and biofilms of pseudomonas aeruginosa and staphylococcus aureus. Int J Nanomed. 14:3861–3874. doi:10.2147/IJN.S202734.
   PubMed Web of Science ®Google Scholar
• Bamidele AT, Songca SP, Oluwafemi OS. 2019. Application of porphyrins in antibacterial photodynamic therapy. Free Radic Biol Med. 24:2456. doi:10.3390/molecules24132456
   Google Scholar
• Cieplik F, Deng D, Crielaard W, Buchalla W, Hellwig E, Al-Ahmad A, Maisch T. 2018. Antimicrobial photodynamic therapy–what we know and what we don’t. Crit Rev Microbiol. 44:571–589. doi:10.1080/1040841X.2018.1467876.
   PubMed Web of Science ®Google Scholar
• CLSI. 2015. Performance standards for antimicrobial susceptibility testing; Twenty-Second Informational Supplement Clinical and Laboratory Standards Institute.
   Google Scholar
• da Fonseca ADS, Mencalha AL, de Paoli F. 2021. Antimicrobial photodynamic therapy against Acinetobacter baumannii. Photodiagn Photodyn Ther. 35:102430. doi:10.1016/j.pdpdt.2021.102430.
   PubMed Web of Science ®Google Scholar
• Dai T, Tegos GP, Lu Z, Huang L, Zhiyentayev T, Franklin MJ, Baer DG, Hamblin MR. 2009. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother. 53:3929–3934. doi:10.1128/AAC.00027-09.
   PubMed Web of Science ®Google Scholar
• Dharmaratne P, Sapugahawatte DN, Wang B, Chan CL, Lau KM, Lau C, Fung KP, Ng DK, IP M. 2020. Contemporary approaches and future perspectives of antibacterial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA): a systematic review. Eur J Med Chem. 200:112341. doi:10.1016/j.ejmech.2020.112341.
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 5:939–951. doi:10.1038/nrmicro1789.
   PubMed Web of Science ®Google Scholar
• Doern CD. 2014. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol. 52:4124–4128. doi:10.1128/JCM.01121-14.
   PubMed Web of Science ®Google Scholar
• Fekrirad Z, Darabpour E, Kashef N. 2021. Eradication of Acinetobacter baumannii planktonic and biofilm cells through erythrosine-mediated photodynamic inactivation augmented by acetic acid and chitosan. Curr Microbiol. 78:879–886. doi:10.1007/s00284-021-02350-x.
   PubMed Web of Science ®Google Scholar
• Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, Seo CH, Park Y. 2014. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Aicinetobacter baumannii strains. Antimicrob Agents Chemother. 58:1622–1629. doi:10.1128/AAC.02473-13.
   PubMed Web of Science ®Google Scholar
• Halicki PCB, Radin V, Von Groll A, Nora MV, Pinheiro AC, Da Silva PEA, Ramos DF. 2020. Antibiofilm potential of arenecarbaldehyde 2-pyridinylhydrazone derivatives against Acinetobacter baumannii. Microb Drug Resist. 26:1429–1436. doi:10.1089/mdr.2019.0185.
   PubMed Web of Science ®Google Scholar
• Hu X, Huang YY, Wang Y, Wang X, Hamblin MR. 2018. Antimicrobial photodynamic therapy to control clinically relevant biofilm infections. Front Microbiol. 9:1299–1224. doi:10.3389/fmicb.2018.01299.
   PubMed Web of Science ®Google Scholar
• Jackson N, Czaplewski L, Piddock LJV. 2018. Discovery and development of new antibacterial drugs: Learning from experience? J Antimicrob Chemother. 73:1452–1459. doi:10.1093/jac/dky019.
   PubMed Web of Science ®Google Scholar
• Jang IA, Kim J, Park W. 2016. Endogenous hydrogen peroxide increases biofilm formation by inducing exopolysaccharide production in Acinetobacter oleivorans DR1. Sci Rep. 6:21121–21112. doi:10.1038/srep21121.
   PubMed Web of Science ®Google Scholar
• Joly-Guillou ML. 2005. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 11:868–873. doi:10.1111/j.1469-0691.2005.01227.x.
   PubMed Web of Science ®Google Scholar
• Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, Fantetti L, Chiti G, Roncucci G. 2006. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med. 38:468–481. doi:10.1002/lsm.20361.
   PubMed Web of Science ®Google Scholar
• Jornada DC, Garcia R de Q, da Silveira CH, Misoguti L, Mendonça CR, Santos RCV, De Boni L, Iglesias BA. 2021. Investigation of the triplet excited state and application of cationic meso-tetra(cisplatin)porphyrins in antimicrobial photodynamic therapy. Photodiagn Photodyn Ther. 35:102459. doi:10.1016/j.pdpdt.2021.102459.
   PubMed Web of Science ®Google Scholar
• Li J, Qin M, Liu C, Ma W, Zeng X, Ji Y. 2020. Antimicrobial photodynamic therapy against multidrug-resistant Acinetobacter baumannii clinical isolates mediated by aloe-emodin: An in vitro study. Photodiagn Photodyn Ther. 29:101632. doi:10.1016/j.pdpdt.2019.101632.
   PubMed Web of Science ®Google Scholar
• Nemec A, Krizova L, Maixnerova M, Sedo O, Brisse S, Higgins PG. 2015. Acinetobacter seifertii sp. nov., a member of the acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens. Int J Syst Evol Microbiol. 65:934–942. doi:10.1099/ijs.0.000043.
   PubMed Web of Science ®Google Scholar
• Nitzan Y, Ashkenazi H. 2001. Photoinactivation of Acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths. Curr Microbiol. 42:408–414. doi:10.1007/s002840010238.
   PubMed Web of Science ®Google Scholar
• Nitzan Y, Balzam-Sudakevitz A, Ashkenazi H. 1998. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J Photochem Photobiol B Biol. 42:211–218. doi:10.1016/S1011-1344(98)00073-6
   PubMed Web of Science ®Google Scholar
• Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 52:1–1. doi:10.1093/jac/dkg301
   PubMed Web of Science ®Google Scholar
• Parasuraman P, Anju VT, Sruthil Lal SB, Sharan A, Busi S, Kaviyarasu K, Arshad M, Dawoud TMS, Syed A. 2019. Synthesis and antimicrobial photodynamic effect of methylene blue conjugated carbon nanotubes on E. coli and S. aureus. Photochem Photobiol Sci. 18:563–576. doi:10.1039/C8PP00369F
   PubMed Web of Science ®Google Scholar
• Parasuraman P, Antony AP, Sruthil Lal SB, Sharan A, Siddhardha B, Kasinathan K, Bahkali NA, Dawoud TMS, Syed A. 2019. Antimicrobial photodynamic activity of toluidine blue encapsulated in mesoporous silica nanoparticles against Pseudomonas aeruginosa and Staphylococcus aureus. Biofouling [Internet]. 35:89–103. doi:10.1080/08927014.2019.1570501.
   PubMed Web of Science ®Google Scholar
• Pendleton JN, Gorman SP, Gilmore BF. 2013. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti-Infect Ther. 11:297–308. doi:10.1586/eri.13.12.
   PubMed Web of Science ®Google Scholar
• Rapacka-Zdończyk A, Woźniak A, Michalska K, Pierański M, Ogonowska P, Grinholc M, Nakonieczna J. 2021. Factors determining the susceptibility of bacteria to antibacterial photodynamic inactivation. Front Med (Lausanne). 8:642609. doi:10.3389/fmed.2021.642609.
   PubMed Web of Science ®Google Scholar
• Rossi GG, Guterres KB, da Silveira CH, Moreira KS, Burgo TAL, Iglesias BA, de Campos MMA. 2020. Peripheral tetra-cationic Pt(II) porphyrins photo-inactivating rapidly growing mycobacteria: first application in mycobacteriology. Microb Pathog. 148:104455. doi:10.1016/j.micpath.2020.104455.
   PubMed Web of Science ®Google Scholar
• Rossi GG, Guterres KB, Moreira KS, Burgo TAL, de Campos MMA, Iglesias BA. 2021. Photo-damage promoted by tetra-cationic palladium(II) porphyrins in rapidly growing mycobacteria. Photodiagn Photodyn Ther. 36:102514. doi:10.1016/j.pdpdt.2021.102514.
   PubMed Web of Science ®Google Scholar
• Seeger MG, Ries AS, Gressler LT, Botton SA, Iglesias BA, Cargnelutti JF. 2020. In vitro antimicrobial photodynamic therapy using tetra-cationic porphyrins against multidrug-resistant bacteria isolated from canine otitis. Photodiagn Photodyn Ther. 32:101982. doi:10.1016/j.pdpdt.2020.101982
   PubMed Web of Science ®Google Scholar
• Soares Lopes LQ, Ramos AP, Copetti PM, Acunha TV, Iglesias BA, Vianna Santos RC, Machado AK, Sagrillo MR. 2019. Antimicrobial activity and safety applications of meso-tetra(4-pyridyl)platinum(II) porphyrin. Microb Pathog. 128:47–54. doi:10.1016/j.micpath.2018.12.038.
   PubMed Web of Science ®Google Scholar
• Stojiljkovic I, Evavold BD, Kumar V. 2001. Antimicrobial properties of porphyrins. Expert Opin Investig Drugs. 10:309–320. doi:10.1517/13543784.10.2.309.
   PubMed Web of Science ®Google Scholar
• Sułek A, Pucelik B, Kobielusz M, Barzowska A, Dąbrowski JM. 2020. Photodynamic inactivation of bacteria with porphyrin derivatives: effect of charge, lipophilicity, ros generation, and cellular uptake on their biological activity in vitro. Int J Mol Sci. 21:8716–8734. doi:10.3390/ijms21228716
   Web of Science ®Google Scholar
• Theuretzbacher U, Outterson K, Engel A, Karlén A. 2020. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 18:275–285. doi:10.1038/s41579-019-0288-0.
   PubMed Web of Science ®Google Scholar
• Thulshan Jayathilaka EHT, Rajapaksha DC, Nikapitiya C, De Zoysa M, Whang I. 2021. Antimicrobial and anti-biofilm peptide octominin for controlling multidrug-resistant Acinetobacter baumannii. Int J Mol Sci. 22:5353. doi:10.3390/ijms22105353
   PubMed Web of Science ®Google Scholar
• Veiga A, Toledo M da GT, Rossa LS, Mengarda M, Stofella NCF, Oliveira LJ, Gonçalves AG, Murakami FS. 2019. Colorimetric microdilution assay: validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds. J Microbiol Methods. 162:50–61. doi:10.1016/j.mimet.2019.05.003
   PubMed Web of Science ®Google Scholar
• WHO 2020. 2020 Antibacterial agents in clinical and preclinical development: an overview and analysis [Internet]. https://www.who.int/publications/i/item/9789240021303.
   Google Scholar
• Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. 2017. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 30:409–447. doi:10.1128/CMR.00058-16.
   PubMed Web of Science ®Google Scholar
• Wozniak A, Rapacka-Zdonczyk A, Mutters NT, Grinholc M. 2019. Antimicrobials are a photodynamic inactivation adjuvant for the eradication of extensively drug-resistant Acinetobacter baumannii. Front Microbiol. 10:229–213. doi:10.3389/fmicb.2019.00229.
   PubMed Web of Science ®Google Scholar